HCA Holdings Inc (HCA)

Sep 25, 2026

Community Health Systems (CYH) faces challenges in sustaining growth despite increasing patient volumes, primarily due to a weak payer mix with a high percentage of uninsured patients and soft demand for elective procedures. While some demand for elective care appears delayed rather than lost, the company's financial performance was impacted by unfavorable payer mix, higher uncompensated care, and increased specialist fees. Peers like HCA Healthcare and Tenet Healthcare showed stronger revenue growth, indicating the critical role of payer mix and procedure intensity in the healthcare sector.

Sep 25, 2026

BMO Capital initiated coverage on HCA Healthcare with an Outperform rating and a $495 price target. Other analysts also started coverage on Guardian Pharmacy Services, Toro Co, Marvell Technology Inc, and Pulse Biosciences Inc with bullish ratings and specific price targets. These initiations reflect positive outlooks from top Wall Street analysts on the respective companies.

Sep 24, 2026

Travel sellers are expressing optimism about the new joint venture between Royal Caribbean Group and Sandals Resorts, viewing it as an opportunity for new experiences for guests both on land and at sea. The partnership is seen as beneficial for travel advisors, offering new options for clients and enhancing the trade-friendly nature of both brands. This collaboration reinforces Royal Caribbean's positioning as a broader vacation experience company, not just a cruise line.

Sep 24, 2026

HCA Healthcare is investing over $32 million in Mission Health facilities across Western North Carolina to enhance patient care. This significant investment includes nearly $15 million for imaging and diagnostic technology and more than $13 million for surgical, cardiovascular, and procedural care. The initiative aims to strengthen the safety, quality, and capabilities of care by providing advanced equipment and technology to physicians and care teams throughout the region.

Sep 24, 2026

Five HCA-affiliated hospitals in Texas have sued Independence Blue Cross, a Philadelphia-based insurer, over $345,000 in allegedly denied or underpaid claims for eight members, including emergency care. The lawsuit claims the insurer violated federal and state law by requiring prior authorization for emergency services and failing to provide specific clinical reasons for denials. This dispute highlights ongoing issues within the BlueCard Program regarding varying authorization rules and medical necessity standards across different Blue Cross Blue Shield plans.

Sep 24, 2026

QRG Capital Management Inc. reduced its stake in HCA Healthcare by 8.9% in the second quarter, selling 4,290 shares and now holding 44,140 shares valued at approximately $17.2 million. Despite this, institutional investors collectively own a significant 62.73% of HCA. Analysts maintain a "Moderate Buy" rating with an average price target of $463.70, while the company reported strong quarterly earnings and revenue growth.

Sep 22, 2026

Andra AP fonden increased its stake in HCA Healthcare by 21.1% in the second quarter, acquiring an additional 9,800 shares to bring its total holdings to 56,323 shares, valued at approximately $21.96 million. Institutional investors collectively own 62.73% of HCA Healthcare, with several major firms recently adding to their positions. HCA Healthcare surpassed quarterly earnings and revenue expectations, reporting $7.59 EPS and $20.23 billion in revenue, and analysts maintain a "Moderate Buy" rating with an average price target of $462.27.

Sep 22, 2026

HCA Healthcare (NYSE:HCA) has received a consensus "Moderate Buy" rating from twenty-three brokerages, with an average 12-month price target of $462.27. The company recently reported strong quarterly earnings of $7.59 per share, surpassing estimates, and revenue of $20.23 billion, an 8.7% increase year-over-year. HCA also declared a quarterly dividend of $0.78 per share.

Sep 22, 2026

HCA Healthcare is rated a Hold due to a 23% sector discount, but concerns about earnings quality and persistent insider selling. Management has cut 2026 guidance, and while the core business shows resilient demand, forward growth is challenged with negative estimate revisions. The author suggests waiting for a breakout above $436–440 resistance, reduced insider selling, and cleaner financial quarters before considering a buy.

Sep 21, 2026

ResMed (NYSE: RMD) is targeting 12%-14% core EPS growth and 5%-7% core constant-currency revenue growth, driven by increased therapy adoption, resupply activities, product innovation, and margin improvements. The company noted that patients using both GLP-1 drugs and positive airway pressure therapy show higher therapy-start and resupply rates, potentially adding 50-125 basis points to Americas sleep-device growth. ResMed is also strategically reshaping its portfolio through acquisitions like Noctrix, divestments such as MatrixCare, and discontinuing its Astral platform to focus on newer devices.

Sep 21, 2026

ResMed (NYSE:RMD) projects a 12%-14% core EPS growth and 5%-7% constant-currency revenue growth, driven by increased therapy adoption, product innovation, and margin improvements. The company notes that patients using both GLP-1 drugs and positive airway pressure therapy show higher treatment initiation and resupply rates, potentially boosting Americas sleep-device growth by 50-125 basis points. ResMed is also strategically reshaping its portfolio through acquisitions like Noctrix and divestitures such as MatrixCare, while discontinuing the Astral platform.

Sep 21, 2026

HCA Healthcare (HCA) has acquired The College of Health Care Professions to improve staffing and workforce needs by connecting education more closely with its healthcare operations. While the acquisition aims to reduce recruitment costs and improve staffing reliability, its success depends on graduate hiring, retention within HCA's network, and overall cost savings versus educational expenses. The company has a history of successful training programs, but challenges remain in ensuring graduates choose HCA and that the benefits outweigh the ongoing costs of running the educational institution.

Sep 21, 2026

Developers planning a new hospital at State Road 60 and 66th Avenue in Vero Beach indicate that three major hospital systems are interested in occupying the site. While the names are undisclosed, AdventHealth, HCA Florida, and Tenet Healthcare are identified as likely contenders based on their presence in Florida, financial stability, and interest in the Vero Beach market. The article details the financial health and operational scope of each potential candidate, highlighting their suitability for the proposed facility.

Sep 20, 2026

HCA Healthcare (HCA) has acquired The College of Health Care Professions, a move aimed at improving staffing reliability and patient capacity by more closely aligning education with workforce needs. The acquisition builds on HCA's existing education network and prior collaborations with the college for training programs. While this strategy has the potential to reduce recruitment costs and improve staffing, its success hinges on student completion, successful hiring into HCA's network, and long-term retention of graduates.

Sep 20, 2026

Nykredit A/S acquired 36,514 shares of HCA Healthcare, Inc. for approximately $14.2 million during the second quarter, making them a new institutional stakeholder. HCA Healthcare reported strong quarterly results with an 8.7% revenue increase year-over-year and beat analyst earnings expectations, also declaring a $0.78 per share quarterly dividend. Despite a generally positive "Moderate Buy" consensus rating from analysts, the company faces potential risks from slowing elective surgeries, rising bad debt, and ongoing payer disputes.

Sep 18, 2026

Bank of America Corp DE has acquired a new stake in ResMed Inc. (NYSE:RMD) during the second quarter, purchasing 775,424 shares valued at approximately $151.1 million, which represents a 0.53% ownership in the medical equipment provider. Other institutional investors also increased their holdings, with institutional investors and hedge funds collectively owning 54.98% of the company's stock. ResMed recently reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend.

Sep 17, 2026

The HCA Healthcare Foundation has awarded a $25,000 grant to Feeding Southwest Virginia to combat food insecurity in the region. The funds, part of the Healthier Tomorrow Fund, will help provide medically tailored food boxes to individuals with limited access to healthy groceries and those at risk for chronic health conditions. This initiative aims to improve both food access and health outcomes in the community.

Sep 17, 2026

Diana Shipping Inc. CEO Semiramis Paliou exercised warrants on September 11, 2026, through two indirectly owned entities, 4 Sweet Dreams, S.A. and Tuscany Shipping Corp. This transaction resulted in the acquisition of 1,369,120 shares and 4,610,946 shares of Common Stock respectively, at an exercise price of $1.69527 per warrant. Following these exercises, Paliou no longer holds any warrants from the December 2023 distribution through these entities.

Sep 16, 2026

HCA Healthcare Inc. has acquired multiple San Antonio college campuses, including the College of Health Care Professions. This acquisition by the Nashville-based giant is expected to bolster efforts to address significant challenges in the region, particularly in the healthcare sector. The deal highlights a strategic move to strengthen local educational and healthcare resources.

Sep 16, 2026

Alluvium Asset Management's "Conventum – Alluvium Global Fund" increased its holdings in HCA Healthcare (HCA) during Q2 2026 after the stock fell 17.5%. Despite a general market rally, the fund saw a decline, with HCA's share price dip attributed to an overreaction to lower respiratory volumes. The fund now holds 6.4% of HCA, believing it to be undervalued.

Sep 16, 2026

WINTON GROUP Ltd significantly reduced its stake in HCA Healthcare, Inc. by 84.2% in the second quarter, selling 6,203 shares and retaining 1,160 shares valued at $452,000. Despite this, HCA Healthcare continues to receive a "Moderate Buy" consensus rating from analysts with an average price target of $462.64, surpassing its recent opening price of $423.13. The company also reported strong quarterly earnings of $7.59 per share and $20.23 billion in revenue, exceeding analyst expectations.

Sep 15, 2026

ResMed (NYSE:RMD) saw its shares trade up 4.5% on Tuesday, despite lower than average trading volume. The company recently reported strong quarterly earnings, beating analyst estimates with an EPS of $2.95 and an 8.6% increase in revenue year-over-year. Additionally, ResMed raised its quarterly dividend from $0.60 to $0.66 per share, and several analysts increased their price targets for the stock, though the consensus rating remains "Hold."

Sep 14, 2026

HCA Healthcare, Inc. (NYSE:HCA) has declared a quarterly dividend of $0.78 per share, payable on September 30th to shareholders of record as of September 16th. The company reported strong quarterly earnings of $7.59 EPS, surpassing analyst expectations, and revenue grew 8.7% year-over-year to $20.23 billion. Analysts maintain a "Moderate Buy" consensus rating with an average price target of $462.64, highlighting the company's consistent dividend increases and solid financial performance.

Sep 14, 2026

Tidal Investments LLC has increased its stake in ResMed Inc. (NYSE:RMD) by 21.1% in the second quarter, bringing its total holdings to 32,332 shares valued at approximately $6.3 million. The company reported strong quarterly earnings, beating analyst expectations with an EPS of $2.95 and revenue of $1.46 billion, an 8.6% increase year-over-year. Despite a consensus "Hold" rating from analysts and recent target price reductions, ResMed also raised its quarterly dividend from $0.60 to $0.66 per share.

Sep 14, 2026

Corient Private Wealth LP significantly increased its stake in HCA Healthcare Inc. by 106.3% in the second quarter, purchasing an additional 50,861 shares, bringing its total holdings to 98,705 shares valued at $38.485 million. Other institutional investors like California State Teachers Retirement System and BlackRock Inc. also made substantial investments in HCA Healthcare. The article also provides details on HCA Healthcare's stock performance, recent earnings, dividend announcement, and analyst ratings, which currently average a "Moderate Buy" with a target price of $462.64.

Sep 13, 2026

Engineers Gate Manager LP significantly reduced its stake in HCA Healthcare, Inc. by selling 49,528 shares, an 81.2% decrease, leaving them with 11,471 shares valued at $4.47 million. This move comes as other institutional investors, such as California State Teachers Retirement System and BlackRock Inc., have either increased or initiated substantial positions in HCA Healthcare. Analysts generally hold a "Moderate Buy" rating for HCA, with a consensus target price of $462.64.

Sep 12, 2026

HCA Healthcare CEO Sam Hazen addressed challenges at Mission Hospital, including staffing, patient flow, capacity, and community trust during a recent visit to Asheville. He acknowledged past shortcomings and outlined HCA's commitment to improving operations, expanding workforce, and rebuilding confidence by prioritizing patient care and employee satisfaction. Hazen emphasized that regaining trust requires earning it through transparent communication and continuous improvement, rather than simply asking for it.